Joan-Carles Vallvé

1.7k total citations
64 papers, 1.2k citations indexed

About

Joan-Carles Vallvé is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Joan-Carles Vallvé has authored 64 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Cancer Research. Recurrent topics in Joan-Carles Vallvé's work include Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Peroxisome Proliferator-Activated Receptors (12 papers) and Lipoproteins and Cardiovascular Health (7 papers). Joan-Carles Vallvé is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Peroxisome Proliferator-Activated Receptors (12 papers) and Lipoproteins and Cardiovascular Health (7 papers). Joan-Carles Vallvé collaborates with scholars based in Spain, France and Austria. Joan-Carles Vallvé's co-authors include L. Masana, Josep Ribalta, Josefa Girona, Roser Rosales, Sílvia Paredes, Mercedes Heras, Xavier Correig, Rosa Solà, Núria Plana and Eva Hurt‐Camejo and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and Scientific Reports.

In The Last Decade

Joan-Carles Vallvé

60 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joan-Carles Vallvé Spain 18 418 275 202 183 167 64 1.2k
Reiko Ohmori Japan 21 303 0.7× 293 1.1× 151 0.7× 293 1.6× 138 0.8× 76 1.5k
Hülya Yılmaz Türkiye 24 489 1.2× 269 1.0× 296 1.5× 344 1.9× 252 1.5× 134 1.8k
Josephine Cooney United Kingdom 13 232 0.6× 471 1.7× 280 1.4× 207 1.1× 96 0.6× 17 1.5k
David A. Gordon United States 15 628 1.5× 476 1.7× 220 1.1× 331 1.8× 128 0.8× 35 1.7k
Melba Hernandez United States 14 429 1.0× 463 1.7× 164 0.8× 196 1.1× 58 0.3× 15 1.2k
Yunjun Xiao China 21 382 0.9× 136 0.5× 107 0.5× 79 0.4× 207 1.2× 36 1.1k
Bilian Yu China 23 413 1.0× 407 1.5× 274 1.4× 228 1.2× 47 0.3× 62 1.6k
Mario Menschikowski Germany 24 733 1.8× 434 1.6× 260 1.3× 146 0.8× 46 0.3× 61 1.8k
Ornella Guardamagna Italy 24 395 0.9× 606 2.2× 271 1.3× 216 1.2× 61 0.4× 63 1.5k
Philipp Wiesner United States 11 571 1.4× 336 1.2× 148 0.7× 130 0.7× 65 0.4× 16 1.5k

Countries citing papers authored by Joan-Carles Vallvé

Since Specialization
Citations

This map shows the geographic impact of Joan-Carles Vallvé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan-Carles Vallvé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan-Carles Vallvé more than expected).

Fields of papers citing papers by Joan-Carles Vallvé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan-Carles Vallvé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan-Carles Vallvé. The network helps show where Joan-Carles Vallvé may publish in the future.

Co-authorship network of co-authors of Joan-Carles Vallvé

This figure shows the co-authorship network connecting the top 25 collaborators of Joan-Carles Vallvé. A scholar is included among the top collaborators of Joan-Carles Vallvé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan-Carles Vallvé. Joan-Carles Vallvé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vera, Elizabeth, Joan-Carles Vallvé, Victòria Linares, et al.. (2024). Serum Levels of Trace Elements (Magnesium, Iron, Zinc, Selenium, and Strontium) are Differentially Associated with Surrogate Markers of Cardiovascular Disease Risk in Patients with Rheumatoid Arthritis. Biological Trace Element Research. 203(7). 3570–3584. 3 indexed citations
2.
Ibarretxe, Daiana, Roser Rosales, Josefa Girona, et al.. (2024). Enhanced Association of Novel Cardiovascular Biomarkers Fetuin-A and Catestatin with Serological and Inflammatory Markers in Rheumatoid Arthritis Patients. International Journal of Molecular Sciences. 25(18). 9910–9910. 4 indexed citations
3.
Feliu, Albert, Daiana Ibarretxe, Joaquín Escribano, et al.. (2023). Lipoprotein profile assessed by 1H NMR, BMI and blood pressure are associated with vascular alterations in children with familial hypercholesterolaemia. Nutrition Metabolism and Cardiovascular Diseases. 33(10). 2035–2043. 1 indexed citations
4.
Rosales, Roser, et al.. (2021). Plasma expression of microRNA-425-5p and microRNA-451a as biomarkers of cardiovascular disease in rheumatoid arthritis patients. Scientific Reports. 11(1). 15670–15670. 17 indexed citations
5.
Bellés, Montserrat, et al.. (2019). Effect of Radiation on the Expression of CVD-related miRNAs, Inflammation and Endothelial Dysfunction of HUVECs. Anticancer Research. 39(2). 771–780. 6 indexed citations
6.
7.
Masana, L., Josefa Girona, Daiana Ibarretxe, et al.. (2018). Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels—The zero-LDL hypothesis. Journal of clinical lipidology. 12(2). 292–299.e3. 50 indexed citations
8.
Rodríguez, M. Mar, Montse Guardiola, Joan-Carles Vallvé, et al.. (2018). Low‐density lipoprotein net charge is a risk factor for atherosclerosis in lupus patients independent of lipid concentrations. International Journal of Rheumatic Diseases. 22(3). 480–487. 8 indexed citations
9.
Guardiola, Montse, Patricia Echeverría, Marta Domínguez‐Gil González, et al.. (2015). Polymorphisms in LPL , CETP , and HL Protect HIV-Infected Patients from Atherogenic Dyslipidemia in an Allele-Dose-Dependent Manner. AIDS Research and Human Retroviruses. 31(9). 882–888. 5 indexed citations
10.
Merino, Jordi, Aleix Sala‐Vila, Núria Plana, et al.. (2015). Serum palmitoleate acts as a lipokine in subjects at high cardiometabolic risk. Nutrition Metabolism and Cardiovascular Diseases. 26(3). 261–267. 11 indexed citations
11.
Rosales, Roser, et al.. (2015). Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition. PLoS ONE. 10(7). e0133875–e0133875. 16 indexed citations
12.
Merino, Jordi, Aleix Sala‐Vila, Núria Plana, et al.. (2015). Cardiometabolic risk associated with excess of body fat could be explained by adipose tissue derived palmitoleic acid. Atherosclerosis. 241(1). e59–e60. 1 indexed citations
13.
Guardiola, Montse, Joan-Carles Vallvé, Roser Rosales, et al.. (2011). APOA5 gene expression in the human intestinal tissue and its response to in vitro exposure to fatty acid and fibrate. Nutrition Metabolism and Cardiovascular Diseases. 22(9). 756–762. 29 indexed citations
14.
15.
Guardiola, Montse, G. Khoschsorur, Rosa Solà, et al.. (2007). Increased concentrations of circulating vitamin E in carriers of the apolipoprotein A5 gene −1131T>C variant and associations with plasma lipids and lipid peroxidation. Journal of Lipid Research. 48(11). 2506–2513. 17 indexed citations
16.
Vallvé, Joan-Carles, Josefa Girona, Sebastián Paredes, Eva Hurt‐Camejo, & L. Masana. (2006). We-P12:310 TNF alpha -1031 T>C polymorphism is associated with elevated markers of oxidation and with smaller LDL size in subjects with rheumatoid arthritis. Atherosclerosis Supplements. 7(3). 414–414. 1 indexed citations
17.
Ribalta, Josep, Joan-Carles Vallvé, Josefa Girona, & L. Masana. (2003). Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease. Current Opinion in Clinical Nutrition & Metabolic Care. 6(2). 177–187. 52 indexed citations
18.
Svensson, L., Germán Camejo, Anna Cabré, et al.. (2003). Fatty acids modulate the effect of darglitazone on macrophage CD36 expression. European Journal of Clinical Investigation. 33(6). 464–471. 13 indexed citations
19.
Girona, Josefa, et al.. (2001). 2,4-Decadienal downregulates TNF-α gene expression in THP-1 human macrophages. Atherosclerosis. 158(1). 95–101. 17 indexed citations
20.
Ribalta, Josep, A.E. La Ville, Joan-Carles Vallvé, Josefa Girona, & L. Masana. (1998). Evidence against alterations in Lecithin:cholesterol acyltransferase (LCAT) activity in Familial combined hyperlipidemia. Atherosclerosis. 138(2). 383–389. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reiko Ohmori Breakdown of academic impact, for papers by Hülya Yılmaz Breakdown of academic impact, for papers by Josephine Cooney Breakdown of academic impact, for papers by David A. Gordon Breakdown of academic impact, for papers by Melba Hernandez Breakdown of academic impact, for papers by Yunjun Xiao Breakdown of academic impact, for papers by Bilian Yu Breakdown of academic impact, for papers by Mario Menschikowski Breakdown of academic impact, for papers by Ornella Guardamagna Breakdown of academic impact, for papers by Philipp Wiesner
Rankless by CCL
2026